By annika [dot] persson [at] ses [dot] lu [dot] se (Annika Persson, communicator at the Department of Service Studies) - published 20 January 2023 ChatGPT is one of the AI services used in cheating. Academic misconduct has increased with about 200% during the past covid years. As a precaution Lund University has started a project to prevent deception and misleading in examination, whether it’s una

https://www.education.lu.se/en/article/ai-forces-teachers-change-way-courses-are-examined - 2025-07-27

By jessica [dot] nilsson [at] lth [dot] lu [dot] se (Jessica Nilsson, LTH library, Faculty of Engineering) - published 26 January 2023 TorTalk is a speech synthesiser for which the university has held computer licenses for many years. Now the app is also available. This increases accessibility, since you can now have all kinds of texts read aloud, in different kinds of situations and environments.

https://www.education.lu.se/en/article/lund-university-now-holds-license-tortalk-app - 2025-07-27

By rachel [dot] forsyth [at] rektor [dot] lu [dot] se (Elin Bommenel and Rachel Forsyth) - published 27 January 2023 What are AI writing tools and how do they affect our assessments? Three main options for considering AI writing tools in assessment are: 1. to ban their use, 2. to assume that they may be used, and set tasks which incorporate them or 3. require them to be used – to fully incorporate

https://www.education.lu.se/en/article/potential-impact-ai-tools-assessment - 2025-07-27

By peter [dot] kjallkvist [at] ehl [dot] lu [dot] se (Peter Kjällkvist, communicator at Lund University School of Economics and Management) - published 23 February 2023 ChatGPT writes code for a simple website. The AI ​​chat can answer questions, translate, write code, or write an exciting short story. The possibilities fascinate and perhaps worry some, but what is ChatGPT really about? "The way I

https://www.education.lu.se/en/article/there-and-after-chatgpt - 2025-07-27

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 22 June 2020 A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluate

https://www.ludc.lu.se/article/roadmap-precision-medicine-diabetes-care - 2025-07-27

By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 23 June 2020 The research group Nutritional Epidemiology has started a blog, www.nutrition.blogg.lu.se! Esther González-Padilla tells us more about it. Visit nutrition.blogg.lu.se, a blog about nutritional science. ​​​​​What is the blog about?We have started the blog mostly as a tool to inform people, within and outside

https://www.ludc.lu.se/article/new-blog-about-nutriton - 2025-07-27

Published 24 June 2020 Karin Stenkula, Emily Sonestedt and Sebastian Kalamajski have received grants from the The Bo and Kerstin Hjelt Diabetes Foundation. Read about their research projects here. Karin Stenkula, Lund University Diabetes Centre:EHD2: a novel candidate essential for lipid transport and overall glucose homeostasisObesity is one of the main risk factors behind type 2 diabetes and car

https://www.ludc.lu.se/article/hjelt-foundations-grant-holders-2020 - 2025-07-27

Published 13 August 2020 A new COVID-19 antibody test developed by scientists at Lund University in Sweden has shown robust performance upon clinical validation and application. The test detects antibodies in the blood targeting the spike protein of SARS-CoV-2, and determines in just 15 minutes whether a person has had COVID-19, regardless of whether they have had any symptoms. “Unlike other serol

https://www.ludc.lu.se/article/new-rapid-and-robust-covid-19-antibody-test-developed - 2025-07-27

Published 29 August 2020 Last week it was announced that our longtime colleague and LUDC researcher/SUS clinician Martin Ridderstråle has been appointed Senior Vice President of Patient Care in the Novo Nordisk Foundation. This is not only a remarkable achievement by Martin but also goes to show that our environment fosters excellent scientists and outstanding clinicians. Martin is one of the most

https://www.ludc.lu.se/article/senior-vice-president-patient-care-novo-nordisk-foundation - 2025-07-27

Published 25 September 2020 Karl Bacos, assistant researcher at LUDC is the recipient of 2020 years Medeon stipend of 50 000 sek for his innovative work within epigenetics in diabetes.   Medeonstipendiat 2020, Karl Bacos, PhD, docent, Lund University Diabetes Centre, Picture: Sara Liedholm The Medeon stipend is handed out in connection to the acknowledgement of World Diabetes Day in Skåne which ta

https://www.ludc.lu.se/article/karl-bacos-years-recipient-medeon-stipend - 2025-07-27

Published 13 August 2020 In many studies, bariatric surgery has been highlighted as an almost magical method for weight loss and reversing type 2 diabetes. One question that has remained largely unanswered is how the effect of surgery differs from the effects of a strict low-calorie diet. This question has now been examined by researchers at Lund University in Sweden in a study published in the jo

https://www.ludc.lu.se/article/strict-diet-explains-metabolic-effect-gastric-pass-surgery - 2025-07-27

Published 30 September 2020 Metformin is the first-line drug that can lower blood sugar levels in type 2 diabetes patients. One third of patients do not respond to metformin treatment and 5 per cent experience serious side effects, which is the reason many choose to stop medicating. Researchers at Lund University in Sweden have now identified biomarkers that can show in advance how the patient wil

https://www.ludc.lu.se/article/metformin-type-2-diabetes-patients-or-not-researchers-now-have-answer - 2025-07-27

Published 9 October 2020 Should patients with separate variants of type 2 diabetes be treated with different types of drugs? Researchers at Lund University in Sweden and Skåne University Hospital will attempt to answer that question in a new study.   Anders Rosengren (Image: Johan Wingborg) Type 2 diabetes is one of the fastest growing diseases in the world. It is estimated that over 300 million p

https://www.ludc.lu.se/article/new-study-personalized-type-2-diabetes-treatment-launched - 2025-07-27

Published 21 December 2020 Our latest study on COVID-19 transmission risk among healthcare professionals, a collaboration between Prof Magnus Rasmussen (Dep. of Infection Medicine) and Associate Professor Yang De Marinis (Dep. of Clinical Sciences).  The study was conducted on ~500 healthcare professionals and staff members from 9 units at the Skåne University Hospital in Malmö and Lund, as well a

https://www.ludc.lu.se/article/study-covid-19-among-healthcare-professionals - 2025-07-27

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 5 July 2021 Researchers at Lund University Diabetes Centre are studying whether different subgroups of diabetes need different treatment. Newborn babies are already being screened for mutations and genetic tests help families with hereditary breast cancer. Genomic-driven precision medicine (GDPM) is an emerging approach fo

https://www.ludc.lu.se/article/precision-medicine-emerging-approach-complex-diseases - 2025-07-27

By bodil [dot] malmstrom [at] med [dot] lu [dot] se (Bodil Malmström) - published 9 June 2021 Data from participants in Sweden has helped researchers understand the complexity of the corona virus. Photo: Istock During the pandemic, the free COVID Symptom Study app has helped researchers understand the complexity and spread of the corona virus better. “The study has exceeded our expectations since

https://www.ludc.lu.se/article/study-tracks-spread-covid-19-sweden - 2025-07-27

Published 18 June 2021 The grants from the Crafoord Foundation will support a wide range of projects in diabetes research. Photo: Kennet Ruona Researchers from Lund University Diabetes Centre (LUDC) receive 5,3 million SEK in grants from the Crafoord Foundation in southern Sweden. This year, 15 researchers from LUDC are awarded grants for a wide range of projects in diabetes research. In total, re

https://www.ludc.lu.se/article/15-researchers-lund-university-diabetes-centre-receive-millions-funding - 2025-07-27

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 November 2021 Yang De Marinis has led the study, which is published in Nature Communications. Photo: Johan Bävman Type 2 diabetes is a complex disease that can lead to serious health problems. It is important to find ways to predict the disease to take preventive measures. A large interdisciplinary study led by Lund Uni

https://www.ludc.lu.se/article/blood-biomarker-identified-predicts-type-2-diabetes-several-years-diagnosis - 2025-07-27

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 31 August 2021 Current screening methods require multiple blood samples. New research shows that a fingerstick blood test can be sufficient. Photo: Petra Olsson Diabetes researchers have established methods for screening people with an increased risk of developing type 1 diabetes. Current methods require multiple blood sam

https://www.ludc.lu.se/article/improved-screening-efficiency-type-1-diabetes-simplified-blood-draw - 2025-07-27

By petra [dot] olsson [at] med [dot] lu [dot] se (Petra Olsson) - published 12 October 2021 Karl Bacos, a researcher in diabetes and epigenetics, receives a generous grant from the Hjelt Diabetes Foundation. Photo: Petra Olsson Three researchers at Lund University Diabetes Centre (LUDC) receive generous grants from the Hjelt Diabetes Foundation in 2021. Ola Hansson, Karl Bacos and Malin Fex have b

https://www.ludc.lu.se/article/hjelt-foundation-grants-mechanistic-studies-type-2-diabetes - 2025-07-27